Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Afutuzumab

Base Information
  • Chemical Name:Afutuzumab
  • CAS No.:949142-50-1
  • Molecular Formula:
  • Molecular Weight:0
  • Hs Code.:
Afutuzumab

Synonyms:Afutuzumab;GA 101; Immunoglobulin G1, anti-(human CD20 (antigen)) (humanized-mousemonoclonal GA101 heavy chain), disulfide with humanized-mouse monoclonal GA101 k-chain,dimer; Obinutuzumab; Ro 5072759; huMAB<CD20>

Suppliers and Price of Afutuzumab
Supply Marketing:
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • Biosynth Carbosynth
  • Obinutuzumab - Buffer solution
  • 1 mg
  • $ 600.00
Total 15 raw suppliers
Chemical Property of Afutuzumab
Chemical Property:
  • PSA:0.00000 
  • LogP:0.00000 
Purity/Quality:

97% *data from raw suppliers

Obinutuzumab - Buffer solution *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:
Useful:
  • Description In November 2013, the US FDA approved the glycoengineered, type II anti-CD20 antibody obinutuzumab (also known as GA101) in combination with chlorambucil chemotherapy for the treatment of people with previously untreated chronic lymphocytic leukemia (CLL). Obinutuzumab is the first drug approved under the FDA’s breakthrough therapy designation, created in 2012 to quicken the pace of development and review of drugs for serious conditions. The Fc portion of obinutuzumab was glycoengineered to reduce fucosylation of the Fc carbohydrate, resulting in increased FcγRIIIa affinity and antibody-dependent cellular cytotoxicity (ADCC) potency. As expected for a type II antibody, obinutuzumab demonstrated lower complement-mediated cytotoxicity, more potent mediation of cell death via the nonclassical apoptosis pathway and increased ADCC as compared with rituximab in preclinical studies. In addition, obinutuzumab induced a stronger antitumor effect in mouse xenograft models of human lymphoma than rituximab and ofatumumab, supporting clinical investigation of this third generation anti-CD20 antibody.
Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 949142-50-1